Adenoviral infections in hematopoietic stem cell transplantation.
暂无分享,去创建一个
[1] P. Veys,et al. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation , 2005, British journal of haematology.
[2] E. Claas,et al. Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery , 2005, Bone Marrow Transplantation.
[3] J. Atkinson,et al. Localization of Regions in CD46 That Interact with Adenovirus , 2005, Journal of Virology.
[4] V. Saha,et al. Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] M. Schilham,et al. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. , 2005, The Journal of infectious diseases.
[6] R. Handgretinger,et al. Detection of adenovirus‐specific T cells in children with adenovirus infection after allogeneic stem cell transplantation , 2005, British journal of haematology.
[7] S. Dupuis-Girod,et al. In Vitro Susceptibility of Adenovirus to Antiviral Drugs is Species-Dependent , 2005, Antiviral therapy.
[8] C. Rooney,et al. Adenovirus as an emerging pathogen in immunocompromised patients , 2005, British journal of haematology.
[9] R. Medzhitov,et al. Toll-like receptors: linking innate and adaptive immunity. , 2004, Microbes and infection.
[10] D. Muruve,et al. The innate immune response to adenovirus vectors. , 2004, Human gene therapy.
[11] C. Rooney,et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. , 2004, Blood.
[12] L. Eisenlohr,et al. Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele , 2004, Gene Therapy.
[13] M. Schilham,et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] R. Krance,et al. Prompt versus preemptive intervention for EBV lymphoproliferative disease. , 2004, Blood.
[15] C. Fegan,et al. Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[16] H. Heslop,et al. Adoptive immunotherapy for posttransplantation viral infections. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[17] H. Einsele,et al. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. , 2004, Experimental hematology.
[18] C. Rooney,et al. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. , 2004, Blood.
[19] C. Rouzioux,et al. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] A. Gaggar,et al. CD46 is a cellular receptor for group B adenoviruses , 2003, Nature Medicine.
[21] R. M. Burnett,et al. Structural and Phylogenetic Analysis of Adenovirus Hexons by Use of High-Resolution X-Ray Crystallographic, Molecular Modeling, and Sequence-Based Methods , 2003, Journal of Virology.
[22] F. Watzinger,et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. , 2003, Blood.
[23] A. Heim,et al. Rapid and quantitative detection of human adenovirus DNA by real‐time PCR , 2003, Journal of medical virology.
[24] M. Schilham,et al. Extensive Cross-Reactivity of CD4+ Adenovirus-Specific T Cells: Implications for Immunotherapy and Gene Therapy , 2003, Journal of Virology.
[25] M. Horwitz,et al. The impact of adenovirus infection on the immunocompromised host , 2003, Reviews in medical virology.
[26] A. Gaggar,et al. The Interaction between the Fiber Knob Domain and the Cellular Attachment Receptor Determines the Intracellular Trafficking Route of Adenoviruses , 2003, Journal of Virology.
[27] H. Einsele,et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation , 2003, Bone Marrow Transplantation.
[28] S. Akira,et al. Toll-like receptors. , 2003, Annual review of immunology.
[29] C. Fegan,et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. , 2002, Blood.
[30] L. Eisenlohr,et al. The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. , 2002, Human gene therapy.
[31] P. Gavin,et al. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. , 2002, Pediatrics.
[32] Hans-Georg Rammensee,et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. , 2002, Blood.
[33] A. Fischer,et al. Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy. , 2002, Human Gene Therapy.
[34] P. Boulanger,et al. Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response , 2002, Journal of Virology.
[35] N. Kapoor,et al. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[36] E. Holler,et al. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study , 2001, Bone Marrow Transplantation.
[37] A. Davis,et al. Efficient infection of primitive hematopoietic stem cells by modified adenovirus , 2001, Gene Therapy.
[38] A. L. Le Faou,et al. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] L. Elting,et al. Adenovirus infections in adult recipients of blood and marrow transplants. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] M. Peuchmaur,et al. Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children , 2001, Bone Marrow Transplantation.
[41] R. Crystal,et al. Adenovirus Serotype 7 Retention in a Late Endosomal Compartment prior to Cytosol Escape Is Modulated by Fiber Protein , 2001, Journal of Virology.
[42] F. Chisari,et al. Noncytolytic control of viral infections by the innate and adaptive immune response. , 2001, Annual review of immunology.
[43] L. Eisenlohr,et al. Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults. , 2001, Viral immunology.
[44] D. Schendel,et al. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant , 2001, Bone Marrow Transplantation.
[45] N. Goulden,et al. Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation , 2000, Bone Marrow Transplantation.
[46] A. Lieber,et al. Dependence of Adenovirus Infectivity on Length of the Fiber Shaft Domain , 2000, Journal of Virology.
[47] A. Kidd,et al. Adenovirus Type 37 Uses Sialic Acid as a Cellular Receptor , 2000, Journal of Virology.
[48] R. M. Burnett,et al. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.
[49] G. Kreitzer,et al. Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. , 2000, Human gene therapy.
[50] M Pittard,et al. Adenovirus infections in hematopoietic stem cell transplant recipients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] T. Schumacher,et al. Selective Expansion of Cross-Reactive Cd8+ Memory T Cells by Viral Variants , 1999, The Journal of experimental medicine.
[52] W. Wold,et al. Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. , 1999, Current opinion in immunology.
[53] R. Crystal,et al. Fiber Swap between Adenovirus Subgroups B and C Alters Intracellular Trafficking of Adenovirus Gene Transfer Vectors , 1999, Journal of Virology.
[54] A. Wald,et al. Development of a High-Throughput Quantitative Assay for Detecting Herpes Simplex Virus DNA in Clinical Samples , 1999, Journal of Clinical Microbiology.
[55] Urs F. Greber,et al. Microtubule-dependent Plus- and Minus End–directed Motilities Are Competing Processes for Nuclear Targeting of Adenovirus , 1999, The Journal of cell biology.
[56] D. Busch,et al. T Cell Affinity Maturation by Selective Expansion during Infection , 1999, The Journal of experimental medicine.
[57] H. Heslop,et al. Adenovirus infection after pediatric bone marrow transplantation , 1999, Bone Marrow Transplantation.
[58] B. Mercier,et al. Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay. , 1999, Journal of virological methods.
[59] J. Ticehurst,et al. PCR Method for Detection of Adenovirus in Urine of Healthy and Human Immunodeficiency Virus-Infected Individuals , 1998, Journal of Clinical Microbiology.
[60] C. Rooney,et al. Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. , 1998, Human gene therapy.
[61] B. Ramsey,et al. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. , 1998, Pediatrics.
[62] D. Srivastava,et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. , 1998, Blood.
[63] A. Helenius,et al. The role of the nuclear pore complex in adenovirus DNA entry , 1997, The EMBO journal.
[64] P. Pring-Åkerblom,et al. PCR-based detection and typing of human adenoviruses in clinical samples. , 1997, Research in virology.
[65] B. Robertson,et al. Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system , 1996, Journal of clinical microbiology.
[66] C. Rooney,et al. Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro , 1996, Journal of virology.
[67] R. Truitt,et al. Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon , 1996, Journal of virology.
[68] G. Boiteau,et al. J. Virol. Methods , 1996, Journal of Virological Methods.
[69] Malcolm K. Brenner,et al. Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes , 1996, Nature Medicine.
[70] A. Helenius,et al. The role of the adenovirus protease on virus entry into cells. , 1996, The EMBO journal.
[71] D. Schnurr,et al. Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues , 1996, Journal of virology.
[72] S. Riddell,et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.
[73] R. Truitt,et al. Characterization of human proliferative T cell responses to adenovirus. , 1995, The Journal of infectious diseases.
[74] R. Krance,et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation , 1995, The Lancet.
[75] K. Cornetta,et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. , 1994, Blood.
[76] M. Horowitz,et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. , 1994, The Journal of infectious diseases.
[77] S. Riddell,et al. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones. , 1994, Bone marrow transplantation.
[78] P. Pring-Åkerblom,et al. Type- and group-specific polymerase chain reaction for adenovirus detection. , 1994, Research in virology.
[79] J. Wilson,et al. Gene therapy: adenovirus vectors. , 1993, Current opinion in genetics & development.
[80] W. Wold,et al. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. , 1991, Virology.
[81] R. Girones,et al. Polymerase chain reaction for detection of adenoviruses in stool samples , 1990, Journal of clinical microbiology.
[82] W. Wold,et al. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. , 1989, Molecular biology & medicine.